# Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis

> **NCT02061995** · PHASE2 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Severe Osteoporosis

## Interventions

- **DRUG:** PREOB® Intravenous Infusion

## Key facts

- **NCT ID:** NCT02061995
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061995, "Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02061995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*